Original Research
Published on 08 Dec 2025
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression
in Pharmacology of Anti-Cancer Drugs
- 368 views